tiprankstipranks
Trending News
More News >
Shenguan Holdings (Group) Limited (HK:0829)
:0829
Hong Kong Market

Shenguan Holdings (Group) Limited (0829) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0829

Shenguan Holdings (Group) Limited

(0829)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
HK$0.50
▲(78.57% Upside)
Shenguan Holdings' overall stock score is primarily influenced by its mixed financial performance and bearish technical indicators. The strong balance sheet is a positive factor, but operational inefficiencies and cash flow issues are significant concerns. The high dividend yield offers some appeal, but the negative P/E ratio and weak market momentum weigh heavily on the overall score.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage and substantial cash reserves provides financial stability and flexibility for future investments.
Product Diversification
Diversification into health supplements reduces reliance on a single market and taps into growing consumer demand for health-oriented products.
Market Position
Strong partnerships and market reach solidify Shenguan's position in the industry, supporting sustained revenue streams and competitive advantage.
Negative Factors
Inconsistent Revenue Growth
Inconsistent revenue growth indicates potential challenges in market demand or operational execution, affecting long-term financial performance.
Cash Flow Issues
Zero operating cash flow suggests difficulties in cash generation, which can impact the company's ability to fund operations and growth initiatives.
Declining Profit Margins
Declining profit margins may indicate rising costs or pricing pressures, potentially reducing profitability and affecting long-term sustainability.

Shenguan Holdings (Group) Limited (0829) vs. iShares MSCI Hong Kong ETF (EWH)

Shenguan Holdings (Group) Limited Business Overview & Revenue Model

Company DescriptionShenguan Holdings (Group) Limited, an investment holding company, manufactures and sells edible collagen sausage casing products in Mainland China, rest of Asia, and internationally. It also manufactures pharmaceutical products and intermediates, food products, skin care and health care products, bioactive collagen products, and fine chemicals for human usage. The company was incorporated in 2009 and is headquartered in Causeway Bay, Hong Kong. Shenguan Holdings (Group) Limited is a subsidiary of Rich Top Future Limited.
How the Company Makes MoneyShenguan Holdings generates revenue primarily through the sale of its collagen products, which are utilized extensively in the food processing industry, particularly in the production of sausages and other meat products. The company's revenue model is anchored in its ability to produce and supply high-quality collagen casings, which are essential for food manufacturers. Additionally, Shenguan has diversified its income streams by expanding into the health supplement market, offering various collagen-based products directly to consumers. Significant partnerships with food producers and distributors enhance its market reach and contribute to steady revenue growth. Factors such as increasing consumer demand for protein-rich and health-oriented products, along with ongoing investments in production technology, further bolster the company's earnings.

Shenguan Holdings (Group) Limited Financial Statement Overview

Summary
The financial performance shows a stable balance sheet with low leverage and substantial cash reserves, but challenges in revenue growth and cash generation. The income statement and cash flow statement reveal operational inefficiencies and recent cash flow concerns.
Income Statement
62
Positive
The income statement shows a mixed performance. Gross profit margin has decreased over recent years, and the net profit margin has seen fluctuations. Revenue growth has been inconsistent, with a decline in 2024 compared to 2023. EBIT margin is low and even negative in some years, indicating potential operational inefficiencies. However, EBITDA margin remains relatively stable, suggesting some underlying operational strength.
Balance Sheet
78
Positive
The balance sheet is relatively strong with a low debt-to-equity ratio, indicating conservative leverage. The company maintains a high equity ratio, reflecting stability and a solid asset base. Return on equity has been declining, which is a concern, but overall, the company maintains financial resilience with substantial cash reserves.
Cash Flow
55
Neutral
Cash flow performance has been uneven. Operating cash flow was zero in the latest year, indicating potential issues in generating cash from operations. Free cash flow has fluctuated and shows low growth, with no positive trend. The high operating cash flow to net income ratio in previous years indicates good cash generation relative to profits, but recent performance is concerning.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.01B1.02B1.11B1.03B1.17B961.62M
Gross Profit143.78M171.08M170.86M160.47M310.49M239.05M
EBITDA70.13M90.44M178.00M79.11M211.95M186.65M
Net Income-22.15M26.66M31.24M23.57M122.65M90.75M
Balance Sheet
Total Assets2.84B2.83B2.96B3.35B3.31B3.13B
Cash, Cash Equivalents and Short-Term Investments558.60M503.80M824.01M953.95M998.90M717.28M
Total Debt420.07M247.97M277.37M540.73M427.95M151.25M
Total Liabilities710.61M536.49M581.08M834.97M656.48M441.48M
Stockholders Equity2.14B2.30B2.38B2.52B2.66B2.69B
Cash Flow
Free Cash Flow-27.32M-234.02M93.98M34.24M110.55M367.03M
Operating Cash Flow6.23M-143.25M176.45M106.04M179.71M443.14M
Investing Cash Flow137.84M161.69M298.11M44.80M-212.22M-406.53M
Financing Cash Flow-216.13M-161.84M-455.19M-71.04M104.16M-116.79M

Shenguan Holdings (Group) Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.28
Price Trends
50DMA
0.26
Negative
100DMA
0.27
Negative
200DMA
0.28
Negative
Market Momentum
MACD
<0.01
Positive
RSI
45.36
Neutral
STOCH
-16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0829, the sentiment is Negative. The current price of 0.28 is above the 20-day moving average (MA) of 0.27, above the 50-day MA of 0.26, and above the 200-day MA of 0.28, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.36 is Neutral, neither overbought nor oversold. The STOCH value of -16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0829.

Shenguan Holdings (Group) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$1.01B8.425.08%10.44%-1.19%-9.05%
63
Neutral
HK$981.63M93.530.79%0.00%-1.70%104.41%
63
Neutral
HK$1.09B2.4110.38%5.38%-6.58%16.23%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
HK$856.08M-36.30-0.99%15.38%-4.42%-157.03%
44
Neutral
HK$1.18B0.7842.14%-81.25%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0829
Shenguan Holdings (Group) Limited
0.27
0.01
4.33%
HK:1583
Qinqin Foodstuffs Group (Cayman) Company
1.30
0.31
31.05%
HK:2317
Vedan International (Holdings) Ltd.
0.66
0.22
50.00%
HK:3838
China Starch Holdings Limited
0.18
<0.01
5.17%
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.07
-0.03
-29.29%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 15, 2025